Believe In Me – Trademark Portfolio
Entity Type: 99
Believe In Me holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include BELIEVE IN ME. The owner is based in Seattle, WA.
107 Spring St.
2nd Floor
Seattle, WA 98104
Showing of trademarks Trademarks
Trademark Classifications
Believe In Me's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Believe In Me have?
Believe In Me has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Believe In Me file in?
Believe In Me files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Believe In Me's most well-known trademarks?
Believe In Me's registered trademark portfolio includes well-known marks such as BELIEVE IN ME. These are among 1 currently registered trademark in the portfolio.
What is Believe In Me's trademark registration success rate?
Believe In Me has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.